minimized bone removal and increased fusion potential compared to a posterolateral cylindrical-threaded single-implant system. Expansion of SCS Systems Into the PDN Market: Nevro’s focus on ...
Total U.S. permanent implant procedures declined ... powers the HFX iQ spinal cord stimulation (SCS) system. In addition to the U.S. market release, Nevro introduced the HFX iQ SCS system in ...
StockNews.com assumed coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical equipment provider’s stock.
29 天
Zacks.com on MSNNevro Q4 Earnings & Revenues Beat Estimates, Gross Margin DownNevro Corp. NVRO reported a loss ... are affected by ongoing softness in the U.S. SCS market and competitive pressures. Total ...
minimized bone removal and increased fusion potential compared to a posterolateral cylindrical-threaded single-implant system. Expansion of SCS Systems Into the PDN Market: Nevro’s focus on expanding ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果